Dapabetic 10mg Tablet
Marketer
Kepran Healthcare
Salt Composition
Dapagliflozin (10mg)
Overview Dapabetic 10mg Tablet
Glycemia-10 tablets (10mg) are indicated for managing type 2 diabetes, either independently or as part of a multi-drug regimen. This medication effectively lowers elevated blood glucose, thus mitigating the risk of severe diabetic complications and cardiovascular events. Glycemia-10 can be administered with or without food, consistently at the same time daily, as determined by your physician. Discontinuation requires medical consultation, as abrupt cessation may lead to hyperglycemia and potentially serious consequences such as renal impairment and vision loss. This medication forms one component of a comprehensive diabetes management plan, encompassing dietary modifications, physical activity, and weight management under professional guidance. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Significant fluid loss is possible; ample hydration is essential to avoid dehydration. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing treatment, disclose any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Limit alcohol consumption during treatment to reduce the likelihood of adverse reactions. Regular blood glucose monitoring is crucial throughout the treatment period.
Uses of Dapabetic 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapabetic 10mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapabetic 10mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapabetic 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapabetic 10mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 10mg Dapabetic tablet whole; do not crush, chew, or divide it. While this medication can be taken with or without food, consistency in timing is recommended.
How Dapabetic 10mg Tablet works:
Glucodown 10mg tablets are used to manage diabetes. They function by facilitating the excretion of surplus glucose via the urinary tract.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Dapabetic 10mg tablets is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Dapabetic 10mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Dapabetic 10mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyUNSAFE
Individuals with kidney impairment should likely refrain from using Dapabetic 10mg tablets due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Ten-milligram Dapabetic tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dapabetic 10mg Tablet :
Should you forget to take your Dapabetic 10mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Dapabetic 10mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavioral Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
3,018 People bought this recently